Cargando…

Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA

BACKGROUND: To establish a safe and accurate method for detecting SARS-CoV-2 IgM and IgG, we assessed the impact of sera after heat-inactivation on the SARS-CoV-2 IgM and IgG levels measured by ELISA-immunoassay. METHODS: The serum samples of 62 patients with COVID-19 and 18 healthy controls were co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xiumei, Zhang, Ruyi, An, Taixue, Li, Qiang, Situ, Bo, Ou, Zihao, Wu, Changmeng, Yang, Biao, Tian, Peifu, Hu, Yuhai, Ping, Baohong, Wang, Qian, Zheng, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305743/ https://www.ncbi.nlm.nih.gov/pubmed/32569631 http://dx.doi.org/10.1016/j.cca.2020.06.032

Ejemplares similares

EDTA-K(2) Improves the Detection Sensitivity of SARS-CoV-2 IgM and IgG Antibodies by Chelating Colloidal Gold in the Immunochromatographic Assay
por: Hu, Xiumei, et al.
Publicado: (2021)

Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia
por: Hii, Shirley Yi Fen, et al.
Publicado: (2017)

Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS‐CoV‐2
por: Hu, Xiumei, et al.
Publicado: (2020)

Analytical Performance of the RIDASCREEN(®) Hantavirus Puumala IgG/IgM ELISA Assay
por: Depypere, Melissa, et al.
Publicado: (2020)

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
por: Van Elslande, J., et al.
Publicado: (2020)

Development of Nipah virus-specific IgM & IgG ELISA for screening human serum samples
por: Shete, Anita M., et al.
Publicado: (2022)

Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
por: Xue, Jun-biao, et al.
Publicado: (2022)

Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection
por: Kikuti, Mariana, et al.
Publicado: (2018)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Potential False-Positive and False-Negative Results for COVID-19 IgG/IgM Antibody Testing After Heat-Inactivation
por: Lin, Jie, et al.
Publicado: (2021)

Serologic Tests of IgG and IgM Antibodies and IgG Avidity for Diagnosis of Ocular Toxoplasmosis
por: Rahimi-Esboei, Bahman, et al.
Publicado: (2018)

Helper T cells reacting to idiotype on IgG but not IgM
Publicado: (1985)

Simultaneous Quantification of Anticardiolipin IgG and IgM by Time Resolved Fluoroimmunoassay
por: Hu, Zhigang, et al.
Publicado: (2016)

Patterns of IgG and IgM antibody response in COVID-19 patients
por: Liu, Xuemei, et al.
Publicado: (2020)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

The validity of diagnostic cut-offs for commercial and in-house scrub typhus IgM and IgG ELISAs: A review of the evidence
por: Saraswati, Kartika, et al.
Publicado: (2019)

Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test
por: Kulkarni, Ruta, et al.
Publicado: (2021)

Development of monoclonal antibody based IgG and IgM ELISA for diagnosis of severe fever with thrombocytopenia syndrome virus infection
por: Zhang, Mei, et al.
Publicado: (2022)

Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019)

Detection of serum IgM and IgG for COVID-19 diagnosis
por: Zhong, Ling, et al.
Publicado: (2020)

The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021)

Rheumatoid factor IgM autoantibodies control IgG homeostasis
por: Nicolò, Antonella, et al.
Publicado: (2022)

Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
por: Clendenen, T. V., et al.
Publicado: (2022)

Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits
por: Al-Jighefee, Hadeel T., et al.
Publicado: (2021)

Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2
por: Liu, Pan-pan, et al.
Publicado: (2021)

In Men at Risk of HIV Infection, IgM, IgG1, IgG3 and IgA Reach the Human Foreskin Epidermis
por: Lemos, Maria P., et al.
Publicado: (2015)

IgG, IgM and IgA antibodies against the novel polyprotein in active tuberculosis
por: Feng, Xiaoyan, et al.
Publicado: (2014)

Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
por: Muthana, Saddam M., et al.
Publicado: (2015)

Kinetics of non-structural protein 1, IgM and IgG antibodies in dengue type 1 primary infection
por: Hu, Dongmei, et al.
Publicado: (2011)

MONOCLONAL PRODUCTION OF BOTH IgM AND IgG1 ANTIHAPTEN ANTIBODY
por: Press, Joan L., et al.
Publicado: (1973)

IgG and IgM autoantibody differences in discoid and systemic lupus patients
por: Chong, Benjamin F., et al.
Publicado: (2012)

Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013)

Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
por: Hou, Hongyan, et al.
Publicado: (2020)

Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Erratum: Rheumatoid factor IgM autoantibodies control IgG homeostasis
Publicado: (2022)

Storage and stability of IgG and IgM monoclonal antibodies dried on filter paper and utility in Neisseria meningitidis serotyping by Dot-blot ELISA
por: Ferraz, Aline S, et al.
Publicado: (2008)

Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples
por: Ibrahim, Essam H., et al.
Publicado: (2021)

Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries
por: Begeman, Ian J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cetihmd527t7shsrffqh8049l4